Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

As Robert F. Kennedy Jr. settles into his role as President Donald Trump’s health secretary, one major promise he’s made is ...

False or misleading claims made in drug advertisements may harm persons who rely on those claims. Direct-to-consumer advertising of prescription drugs may result in inappropriate prescribing of ...

A pill used in most U.S. abortions has been ensnared in politics for years, and many Americans wonder whether it will be ...

Whether or not telehealth companies are under FDA jurisdiction when marketing and promoting prescription drugs has been under ...

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...

With conventional drug advertising, notes Diana Zuckerman, director of the National Research Center for Women and Families in Washington, DC, at least you have a clear idea of who is sponsoring ...

However, when it comes to medical product advertising, caution is necessary to avoid potential legal and regulatory pitfalls. A quick survey of recent FDA advertising actions provides insight into ...

While the Supreme Court's ruling was directed at the advertising restrictions in section 503A of the Federal Food, Drug, and Cosmetic Act, it had the effect of invalidating the entire section ...